van den Heuvel-Eibrink MM - Search Results

1

CBL mutations do not frequently occur in paediatric acute myeloid leukaemia.

Coenen EA, Driessen EM, Zwaan CM, Stary J, Baruchel A, de Haas V, de Bont ES, Reinhardt D, Kaspers GJ, Arentsen-Peters ST, Meyer C, Marschalek R, Pieters R, Stam RW, van den Heuvel-Eibrink MM. Coenen EA, et al. Br J Haematol. 2012 Dec;159(5):577-84. doi: 10.1111/bjh.12068. Epub 2012 Oct 1. Br J Haematol. 2012. PMID: 23025505 Free article.

2

MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia.

van den Heuvel-Eibrink MM, van der Holt B, te Boekhorst PA, Pieters R, Schoester M, Löwenberg B, Sonneveld P. van den Heuvel-Eibrink MM, et al. Br J Haematol. 1997 Oct;99(1):76-83. doi: 10.1046/j.1365-2141.1997.3343148.x. Br J Haematol. 1997. PMID: 9359506 Free article.

3

The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.

van den Heuvel-Eibrink MM, Sonneveld P, Pieters R. van den Heuvel-Eibrink MM, et al. Int J Clin Pharmacol Ther. 2000 Mar;38(3):94-110. doi: 10.5414/cpp38094. Int J Clin Pharmacol Ther. 2000. PMID: 10739113 Review.

4

MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7.

van den Heuvel-Eibrink MM, Wiemer EA, de Boevere MJ, Slater RM, Smit EM, van Noesel MM, van der Holt B, Schoester M, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Leukemia. 2001 Mar;15(3):398-405. doi: 10.1038/sj.leu.2402027. Leukemia. 2001. PMID: 11237063

5

Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML).

van den Heuvel-Eibrink MM, Wiemer EA, Kuijpers M, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Leukemia. 2001 May;15(5):855-6. doi: 10.1038/sj.leu.2402112. Leukemia. 2001. PMID: 11368449 No abstract available.

6

van den Heuvel-Eibrink MM, Wiemer EA, de Boevere MJ, van der Holt B, Vossebeld PJ, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Blood. 2001 Jun 1;97(11):3605-11. doi: 10.1182/blood.v97.11.3605. Blood. 2001. PMID: 11369657 Free article.

7

Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).

van den Heuvel-Eibrink MM, Wiemer EA, Prins A, Meijerink JP, Vossebeld PJ, van der Holt B, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Leukemia. 2002 May;16(5):833-9. doi: 10.1038/sj.leu.2402496. Leukemia. 2002. PMID: 11986944

8

Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.

Stam RW, van den Heuvel-Eibrink MM, den Boer ML, Ebus ME, Janka-Schaub GE, Allen JD, Pieters R. Stam RW, et al. Leukemia. 2004 Jan;18(1):78-83. doi: 10.1038/sj.leu.2403168. Leukemia. 2004. PMID: 14574327

9

Childhood paroxysmal nocturnal haemoglobinuria (PNH), a report of 11 cases in the Netherlands.

van den Heuvel-Eibrink MM, Bredius RG, te Winkel ML, Tamminga R, de Kraker J, Schouten-van Meeteren AY, Bruin M, Korthof ET. van den Heuvel-Eibrink MM, et al. Br J Haematol. 2005 Feb;128(4):571-7. doi: 10.1111/j.1365-2141.2004.05337.x. Br J Haematol. 2005. PMID: 15686469 Free article. Review.

10

No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.

van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, van der Sluis IM, Krenning EP, Pieters R, van den Heuvel-Eibrink MM. van Beek RD, et al. Pediatr Blood Cancer. 2006 Jan;46(1):88-93. doi: 10.1002/pbc.20437. Pediatr Blood Cancer. 2006. PMID: 15926166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

620 results

Search Page

Filters